Cargando…
Generation of a Nebulizable CDR-Modified MERS-CoV Neutralizing Human Antibody
Middle East respiratory syndrome coronavirus (MERS-CoV) induces severe aggravating respiratory failure in infected patients, frequently resulting in mechanical ventilation. As limited therapeutic antibody is accumulated in lung tissue following systemic administration, inhalation is newly recognized...
Autores principales: | Kim, Sang Il, Kim, Sujeong, Kim, Jinhee, Chang, So Young, Shim, Jung Min, Jin, Jongwha, Lim, Chungsu, Baek, Songyi, Min, Ji-Young, Park, Wan Beom, Oh, Myoung-don, Kim, Seungtaek, Chung, Junho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6829326/ https://www.ncbi.nlm.nih.gov/pubmed/31614869 http://dx.doi.org/10.3390/ijms20205073 |
Ejemplares similares
-
An anti-Gn glycoprotein antibody from a convalescent patient potently inhibits the infection of severe fever with thrombocytopenia syndrome virus
por: Kim, Ki Hyun, et al.
Publicado: (2019) -
Ibuprofen, a traditional drug that may impact the course of COVID-19 new effective formulation in nebulizable solution
por: García, Néstor H., et al.
Publicado: (2020) -
Identification of 4-anilino-6-aminoquinazoline derivatives as potential MERS-CoV inhibitors
por: Lee, Jun Young, et al.
Publicado: (2020) -
Safe, high-throughput screening of natural compounds of MERS-CoV entry inhibitors using a pseudovirus expressing MERS-CoV spike protein
por: Kim, Ji Yeun, et al.
Publicado: (2018) -
Seroprevalence of Middle East respiratory syndrome coronavirus
(MERS-CoV) in public health workers responding to a MERS outbreak in Seoul,
Republic of Korea, in 2015
por: Ryu, Boyeong, et al.
Publicado: (2019)